Saturday, February 13, 2016

Daniel Hoffman

Extortionate prices aren't necessary for better, new drugs

Monday, November 9, 2015, 3:01 PM
In late October we noted an item from Politico about the pharmaceutical industry's lobby, PhRMA (the Pharmaceutical Research and Manufacturers Association) meeting to launch a massive PR campaign aimed at defending increasingly unaffordable drug prices. Last week, the first product of those meetings... Read more

Another pharma flack to deal with

Friday, October 30, 2015, 11:18 AM
The steep price increases that constitute a routine part of the pharmaceutical business keep rolling along. Some industry apologists have recently been touting a report by the consulting firm Truveris that found lower price increases for drugs this year compared to 2014. Although they're correct about... Read more

When a Conservative Business Paper Questions Pharma's Pricing

Tuesday, October 20, 2015, 8:59 AM
It actually shouldn't be too surprising when the bastion of American corporate capitalism, Rupert Murdoch's Wall Street Journal, prints a front-page article deriding the pharmaceutical industry for its regular, cartel-like price increases. After all, even before the Chicago School of economists and... Read more

U.S. Public Complains About Drug Prices But Takes No Action

Monday, October 5, 2015, 5:30 AM
Drug prices are rising faster than most other health care costs and while surveys show that the American public resents the situation – 73 percent now favor price controls – the costs still keep going up. It seems that unaffordable medications have now taken their place in American life... Read more

A 5,455 percent price increase? Expect more of it

Thursday, September 24, 2015, 12:37 PM
After Pope Francis's visit to the U.S., possibly the biggest news item this week has been the depraved price increase that Turing Pharmaceuticals posted for its drug, Daraprim. Although the 5,455 percent that Turing hiked Daraprim's price is astounding, the absolute daily price is less than that of... Read more

Will high drug prices boomerang on pharma?

Monday, September 14, 2015, 3:10 PM
As surely as the seasons change and the tides rise, pharma will continue raising the prices of medications wherever and whenever it can. In one example from last week, the non-profit Institute for Clinical and Economic Review (ICER) found that the new class of cholesterol medications, the PCSK-9s... Read more

Excuses for price gouging on drugs don't hold water

Friday, September 4, 2015, 11:06 AM
The pharmaceutical industry is feeling rising heat from all directions as a result of its excessive price increases that reflect a contempt for consumers and the nation's economy. In response, pharma has been mobilizing its defenders in the media and academia to deploy the industry's standard mixture... Read more

Just how bad are drug price increases?

Thursday, September 3, 2015, 10:33 AM
The magnitude of the problem is astonishing. Although expensive specialty drugs are only 2-3 percent of all prescriptions, they account for approximately one-third of all medication costs. According to a report late last year by IMS, a market data supplier for the pharmaceutical industry, the costs... Read more

How much to cut drug prices?

Monday, August 31, 2015, 5:30 AM
On August 20, the Kaiser Family Foundation published the latest results from its poll that tracks health care opinions among American consumers. The pollsters found that only slightly more than four in 10 respondents (42 percent) have a positive view of pharma companies. That ranks the pharma industry... Read more

Proposals to make drug pricing more transparent

Monday, August 24, 2015, 5:30 AM
Americans are starting to feel the pinch from high drug prices. In a survey recently reported by Consumer Reports, one-third of Americans said they paid an average of $39 above the usual cost for their latest prescription. One in ten said they paid $100 or more out-of-pocket. Forty per cent of people... Read more
About this blog

Check Up is a blog for savvy health consumers, covering the latest developments, discoveries, and debates from the Philadelphia area and beyond.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Charlotte Sutton Health and Science Editor, Philadelphia Inquirer
Tom Avril Inquirer Staff Writer, heart health and general science
Stacey Burling Inquirer Staff Writer, neuroscience and aging
Marie McCullough Inquirer Staff Writer, cancer and women's health
Don Sapatkin Inquirer Staff Writer, public health
David Becker, M.D. Board certified cardiologist, Chestnut Hill Temple Cardiology
Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on
letter icon Newsletter